Incyte
INCY
#993
Rank
โ‚ฌ21.50 B
Marketcap
105,51ย โ‚ฌ
Share price
-1.64%
Change (1 day)
17.62%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2026 (TTM): โ‚ฌ0.67 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚ฌ6.01 Billion. In 2025 the company made an earning of โ‚ฌ1.51 Billion, an increase over its 2024 earnings that were of โ‚ฌ0.28 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.67 B-55.19%
2025 โ‚ฌ1.51 B425.68%
2024 โ‚ฌ0.28 B-62.04%
2023 โ‚ฌ0.75 B57.66%
2022 โ‚ฌ0.48 B-7.24%
2021 โ‚ฌ0.51 B-345.65%
2020 -โ‚ฌ0.22 Billion-147.7%
2019 โ‚ฌ0.44 B322.02%
2018 โ‚ฌ0.10 B-136.94%
2017 -โ‚ฌ0.29 Billion-390.76%
2016 โ‚ฌ97.8 M1322%
2015 โ‚ฌ6.87 M-115.56%
2014 -โ‚ฌ44.21 Million-41.4%
2013 -โ‚ฌ75.45 Million87.67%
2012 -โ‚ฌ40.2 Million-74.9%
2011 -โ‚ฌ0.17 Billion843.59%
2010 -โ‚ฌ16.97 Million-88.68%
2009 -โ‚ฌ0.15 Billion1.37%
2008 -โ‚ฌ0.15 Billion86.16%
2007 -โ‚ฌ79.46 Million17.64%
2006 -โ‚ฌ67.54 Million-28.62%
2005 -โ‚ฌ94.62 Million-36.1%
2004 -โ‚ฌ0.15 Billion-2.03%
2003 -โ‚ฌ0.16 Billion22.26%
2002 -โ‚ฌ0.13 Billion-27.39%
2001 -โ‚ฌ0.18 Billion198.72%
2000 -โ‚ฌ57 Million132.2%
1999 -โ‚ฌ24.55 Million-556.86%
1998 โ‚ฌ5.37 M-37.23%
1997 โ‚ฌ8.55 M-259.32%
1996 -โ‚ฌ5.38 Million-45.87%
1995 -โ‚ฌ9.93 Million-9.17%
1994 -โ‚ฌ10.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ11.51 B 1,487.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ6.34 B 775.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.66 B 4,266.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.06 B 1,288.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ55.46 M-92.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚ฌ17.34 Million-102.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ63.05 Million-108.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚ฌ26.45 Million-103.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ50.32 Million-106.94%๐Ÿ‡บ๐Ÿ‡ธ USA